Moreover, BRD4 has been found to be concentrated at the Notch1 promoter region, thus modulating the Notch1 signaling pathway that is involved in the regulation of the self-renewal and tumorigenicity of glioma stem cells [16]. Here, NOTCH1 is linked to central nervous system cancer.